:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2Fevidation-wordmark-black-cmyk.png)
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Fkate-binghama-banner.jpg)
SV Health Investors Announces Licensing and Research Collaboration between Sitryx and Lilly to Discover and Develop New Immunometabolic Medicines
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FSutro-Biopharma-Logo.png){kind=logo}
:no_upscale()/svhi.fra1.digitaloceanspaces.com%2FQurAlis-logo.png)
13 May 2020Portfolio NewsQurAlis raises $42 Million Series A Financing to Develop New Therapies for Amyotrophic Lateral Sclerosis (ALS)
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FNitrome_logo_2020.png)
23 April 2020Portfolio NewsNitrome Biosciences Raises $38M Series A Financing to Advance Therapeutics Targeting a Novel Group of Enzymes involved in Age-related Diseases
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FEvelo.png)
15 April 2020Portfolio NewsEvelo Biosciences Appoints Neil Graham, M.D., M.B.B.S., M.P.H., as Chief Development Officer - an industry veteran who brings deep experience in drug development from leadership roles at Regeneron and Vertex
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FCerevance-Logo-1920-x-1080-002.jpg)
14 April 2020Portfolio NewsCerevance Closes $45 Million Series B Financing - proceeds to fund a diverse pipeline of therapeutics acting on novel targets for brain diseases
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FAlector-Logo.png)
24 March 2020Portfolio NewsAlector Announces the Appointment of Paula Hammond, Ph.D., to the Board of Directors
:no_upscale()/svhi.fra1.digitaloceanspaces.com%2FDementia.jpg)
9 September 2019Portfolio NewsDDF notes the appointment of Christian Jung, PhD as Partner
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FAstronauTX-Logo_200414_111145.png)
12 August 2019Portfolio NewsDDF notes AstronauTx secures £6.5 million Financing with Investment from DDF- 19 June 2017Portfolio NewsDementia Discovery Fund Annual Update
- 1 June 2017Portfolio NewsBicycle Therapeutics Closes £40 Million ($52 Million) in Series B Financing to Advance Clinical Pipeline
- 3 May 2017Portfolio NewsDDF to Invest $5 Million in Cerevance to Seek New Treatments for Dementia
:no_upscale():fill(white)/svhi.fra1.digitaloceanspaces.com%2Flogos%2FAutifony-logo-retina-updated.png)
15 March 2017Portfolio NewsAutifony Therapeutics obtains £1.3 million in funding from Innovate UK and the Dementia Discovery Fund to explore novel approach to treatment of dementia- 28 February 2017Portfolio NewsDDF Acquires Small Molecule Library and Enters Strategic Partnership with Aptuit to Kickstart Dementia Drug Discovery Programmes